Cellectis Historical Financial Ratios
| CLLS Stock | USD 2.13 0.01 0.47% |
Cellectis is presently reporting on over 100 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 3.61 or Days Sales Outstanding of 11.7 K will help investors to properly organize and evaluate Cellectis SA financial condition quickly.
Cellectis |
About Cellectis Financial Ratios Analysis
Cellectis SAFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Cellectis investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Cellectis financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Cellectis history.
Cellectis Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Cellectis SA stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Cellectis sales, a figure that is much harder to manipulate than other Cellectis SA multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Cellectis SA dividend as a percentage of Cellectis stock price. Cellectis SA dividend yield is a measure of Cellectis stock productivity, which can be interpreted as interest rate earned on an Cellectis investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Invested Capital
Invested capital represents the total cash investment that shareholders and debt holders have contributed to Cellectis SA. There are two different methods for calculating Cellectis SA invested capital: operating approach and financing approach. Understanding Cellectis invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.Stock Based Compensation To Revenue
A metric that compares the total value of stock-based compensation granted by a company to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards.Capex To Depreciation
The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.Most ratios from Cellectis' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Cellectis SA current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cellectis SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. At this time, Cellectis' Sales General And Administrative To Revenue is comparatively stable compared to the past year. Research And Ddevelopement To Revenue is likely to gain to 121.89 in 2024, whereas Free Cash Flow Yield is likely to drop (0.17) in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 100.5 | 14.7 | 11.2K | 11.7K | PTB Ratio | 1.71 | 0.82 | 1.89 | 3.61 |
Cellectis fundamentals Correlations
Click cells to compare fundamentals
Cellectis Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cellectis fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 49.07 | 17.08 | 5.13 | 5.05 | 212.39 | 223.01 | |
| Ptb Ratio | 2.37 | 4.58 | 1.71 | 0.82 | 1.89 | 3.61 | |
| Days Sales Outstanding | 71.1 | 25.52 | 100.5 | 14.7 | 11.2K | 11.7K | |
| Book Value Per Share | 8.39 | 7.29 | 5.28 | 2.77 | 1.61 | 1.53 | |
| Free Cash Flow Yield | (0.0524) | (0.1) | (0.11) | (0.33) | (0.93) | (0.16) | |
| Operating Cash Flow Per Share | (1.63) | (1.89) | (2.34) | (1.92) | (0.47) | (0.49) | |
| Stock Based Compensation To Revenue | 1.77 | 0.14 | 0.16 | 0.32 | 6.93 | 7.28 | |
| Capex To Depreciation | 1.88 | 4.71 | 1.19 | 0.13 | 0.0579 | 0.055 | |
| Pb Ratio | 2.37 | 4.58 | 1.71 | 0.82 | 1.89 | 3.61 | |
| Ev To Sales | 28.45 | 14.96 | 3.99 | 4.28 | 143.98 | 151.18 | |
| Free Cash Flow Per Share | (1.94) | (2.99) | (2.78) | (1.97) | (0.49) | (0.51) | |
| Inventory Turnover | 9.96 | 3.93 | 22.59 | 0.0814 | 0.0733 | 0.0696 | |
| Net Income Per Share | (1.93) | (2.14) | (1.71) | (2.17) | (1.92) | (2.02) | |
| Days Of Inventory On Hand | 36.65 | 92.82 | 16.16 | 4.5K | 4.0K | 4.2K | |
| Payables Turnover | 0.39 | 1.47 | 1.53 | 0.0826 | 0.0386 | 0.0367 | |
| Sales General And Administrative To Revenue | 2.83 | 0.6 | 0.51 | 0.91 | 22.27 | 23.38 | |
| Research And Ddevelopement To Revenue | 6.01 | 6.06 | 1.18 | 5.09 | 116.09 | 121.89 | |
| Capex To Revenue | 0.85 | 0.63 | 0.27 | 0.13 | 1.42 | 1.49 | |
| Cash Per Share | 9.0 | 6.97 | 4.17 | 2.32 | 3.87 | 4.22 | |
| Pocfratio | (10.78) | (15.74) | (3.63) | (1.11) | (6.48) | (6.16) | |
| Interest Coverage | (47.41) | (7.09) | (16.01) | (23.68) | (18.33) | (19.25) | |
| Capex To Operating Cash Flow | (0.0717) | (0.19) | (0.58) | (0.0279) | (0.0434) | (0.0455) | |
| Pfcf Ratio | (9.08) | (9.98) | (3.05) | (1.08) | (6.21) | (6.52) | |
| Days Payables Outstanding | 937.62 | 247.62 | 239.09 | 4.4K | 9.4K | 9.9K | |
| Income Quality | 0.77 | 0.6 | 0.82 | 0.84 | 0.21 | 0.2 | |
| Roe | (0.29) | (0.26) | (0.39) | (0.84) | (1.19) | (1.25) | |
| Ev To Operating Cash Flow | (6.25) | (13.78) | (2.82) | (0.94) | (4.39) | (4.17) | |
| Pe Ratio | (8.22) | (17.41) | (4.39) | (0.98) | (1.59) | (1.51) | |
| Ev To Free Cash Flow | (5.26) | (8.74) | (2.38) | (0.91) | (4.21) | (4.42) | |
| Earnings Yield | (0.12) | (0.0574) | (0.23) | (1.02) | (0.63) | (0.6) | |
| Intangibles To Total Assets | 0.00237 | 0.003374 | 0.004852 | 0.002749 | 0.002007 | 0.001907 | |
| Current Ratio | 6.25 | 6.06 | 4.57 | 2.28 | 1.5 | 1.43 | |
| Tangible Book Value Per Share | 8.37 | 7.25 | 5.24 | 2.75 | 1.6 | 1.52 | |
| Receivables Turnover | 5.13 | 14.3 | 3.63 | 24.83 | 0.0326 | 0.031 | |
| Graham Number | 18.93 | 15.83 | 14.64 | 11.24 | 8.34 | 8.9 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cellectis Stock Analysis
When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.